Evaluation of Buproprion in Nicotine Dependence Model
Evaluation of Buproprion in Nicotine Dependence Model
批准号:
7620453
负责人:
M. Imad Damaj
金额:
$15.66万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-06-01 至 2010-05-31
关键词:
AcuteAnimal ModelAntidepressive AgentsAreaAutomobile DrivingBehaviorBiologicalBody TemperatureBrainBupropionCessation of lifeChronicCoupledDependenceDoseEffectivenessEvaluationEventFamilyFoodGoalsIn VitroLeadMeasuresMetabolismModelingMolecular TargetMotor ActivityMusNicotineNicotine DependenceNicotine WithdrawalNicotinic ReceptorsNociceptionNumbersPharmaceutical PreparationsPharmacotherapyPhysical DependencePlayProceduresPropertyPsychological reinforcementRangeRattusReinforcement ScheduleReportingRewardsRoleScheduleSecond-Generation Antidepressive AgentsSelf AdministrationSmokerSpecificityStimulusTestingTherapeuticTobacco useUnited StatesWithdrawalWorkanalogdesiredrug discriminationdrug efficacyextracellularimprovedin vivoinnovationmembermonoaminemouse modelnicotine abusenicotine replacementsmoking cessationtherapy development
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The broad objective of this proposal is to determine mechanisms of action of the clinically useful
antidepressant and smoking cessation aid, bupropion. The underlying hypothesis driving this application is
that a successful smoking cessation pharmacotherapy would at least include a blocking activity at
monoamine transporters and c_413_nAChR subtype. This component will first determine the potential (_4132
nAChR antagonistic properties of selected bupropion, hydroxybupropion and 3-phenyltropane analogs
(provided by Project # 1) on nicotinic acute effects in mice. Compounds found to possess in vitro functional
blocking activity at DA and NE transporters and c_4132nAChR subtype (provided by Projects 1 & 2) will be
assessed for their ability to block the acute effects of nicotine on nociception, body temperature and
locomotor activity in miceAnalogs with potency higher than that of bupropion will be selected for testing in
the nicotine dependence models. These analogs will be evaluated in two nicotine dependence-related
behaviors in mice that models subjective properties and physical dependence-producing effects of nicotine:
drug discrimination and withdrawal signs. These findings also will allow relationships to be defined between
effects of drugs on NET, DAT, or nAChR function in vitro provided in Projects 1 and 2 and drug efficacy in
the nicotine dependence models, thus helping to correlate molecular target profiles with effects on nicotine
dependence. Compounds showing partial or total substitution properties and reversing nicotine withdrawal
signs will be subsequently tested in rat i.v. self-administration
Out of this work leads for new medications development for treatment of nicotine dependence will come.
Our studies will yield information concerning the biological targets (transporters and nicotinic receptors)
involved in bupropion's therapeutic benefits and will improve the limited efficacy of the current smoking
cessation pharmacological strategies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeting Sphingosine-1-phosphate (S1P1) receptors for the treatment of Aromatase Inhibitors-induced Musculoskeletal Symptoms
-
批准号:10668781
-
项目类别:
-
资助金额:$61.39万
-
财政年份:2023
-
负责人:M. Imad Damaj
-
依托单位:
Initial Development of AEG-1 inactivation as a possible strategy for pain treatment
-
批准号:10454012
-
项目类别:
-
资助金额:$117.97万
-
财政年份:2022
-
负责人:M. Imad Damaj
-
依托单位:
VCU Health Education Opportunities for Teachers (HERO-T)
-
批准号:10399423
-
项目类别:
-
资助金额:$10.47万
-
财政年份:2021
-
负责人:M. Imad Damaj
-
依托单位:
VCU Health Education Opportunities for Teachers (HERO-T)
-
批准号:10596118
-
项目类别:
-
资助金额:$10.47万
-
财政年份:2021
-
负责人:M. Imad Damaj
-
依托单位:
Identification of gene variants for alcohol analgesia
-
批准号:9758078
-
项目类别:
-
资助金额:$39.3万
-
财政年份:2019
-
负责人:M. Imad Damaj
-
依托单位:
Identification of gene variants for alcohol analgesia
-
批准号:10380160
-
项目类别:
-
资助金额:$46.03万
-
财政年份:2019
-
负责人:M. Imad Damaj
-
依托单位:
Identification of gene variants for alcohol analgesia
-
批准号:10598056
-
项目类别:
-
资助金额:$45.88万
-
财政年份:2019
-
负责人:M. Imad Damaj
-
依托单位:
Genetic basis of nicotine withdrawal in a reduced complexity cross
-
批准号:10401810
-
项目类别:
-
资助金额:$55.42万
-
财政年份:2018
-
负责人:M. Imad Damaj
-
依托单位:
(PQ12) Peroxisome proliferator-activated receptor alpha agonists as potential treatment for chemotherapy-induced peripheral neuropathy
-
批准号:10198858
-
项目类别:
-
资助金额:$25.94万
-
财政年份:2018
-
负责人:M. Imad Damaj
-
依托单位:
Genetic basis of nicotine withdrawal in a reduced complexity cross
-
批准号:9920699
-
项目类别:
-
资助金额:$58.57万
-
财政年份:2018
-
负责人:M. Imad Damaj
-
依托单位:
(PQ12) Peroxisome proliferator-activated receptor alpha agonists as potential treatment for chemotherapy-induced peripheral neuropathy
-
批准号:9750651
-
项目类别:
-
资助金额:$31.45万
-
财政年份:2018
-
负责人:M. Imad Damaj
-
依托单位:
Project 3: Adolescent Nicotine
-
批准号:9151765
-
项目类别:
-
资助金额:$17.34万
-
财政年份:2016
-
负责人:M. Imad Damaj
-
依托单位:
(PQ9) Mitigation of chemotherapy induced peripheral neuropathy
-
批准号:9892956
-
项目类别:
-
资助金额:$34.26万
-
财政年份:2016
-
负责人:M. Imad Damaj
-
依托单位:
(PQ9) Mitigation of chemotherapy induced peripheral neuropathy
-
批准号:9101341
-
项目类别:
-
资助金额:$36.31万
-
财政年份:2016
-
负责人:M. Imad Damaj
-
依托单位:
Genes and molecular pathways in nicotine dependence and withdrawal
-
批准号:8889863
-
项目类别:
-
资助金额:$8.36万
-
财政年份:2014
-
负责人:M. Imad Damaj
-
依托单位:
Genes and molecular pathways in nicotine dependence and withdrawal
-
批准号:8320538
-
项目类别:
-
资助金额:$30.44万
-
财政年份:2013
-
负责人:M. Imad Damaj
-
依托单位:
Genes and molecular pathways in nicotine dependence and withdrawal
-
批准号:8998014
-
项目类别:
-
资助金额:$30.2万
-
财政年份:2013
-
负责人:M. Imad Damaj
-
依托单位:
Genes and molecular pathways in nicotine dependence and withdrawal
-
批准号:8598866
-
项目类别:
-
资助金额:$30.5万
-
财政年份:2013
-
负责人:M. Imad Damaj
-
依托单位:
Evaluation of Buproprion in Nicotine Dependence Model
-
批准号:7514125
-
项目类别:
-
资助金额:$14.33万
-
财政年份:2007
-
负责人:M. Imad Damaj
-
依托单位:
Role of calcium-dependent mechanisms in nicotine's tolerance and effects
-
批准号:7667762
-
项目类别:
-
资助金额:$21.27万
-
财政年份:2001
-
负责人:M. Imad Damaj
-
依托单位:
海外基金